San Francisco, 94105-3701, CA,
United States
Chronicled
Chronicled, a prominent reseller, system integrator, and consulting company, that plays a vital role in numerous system integration and digital transformation initiatives. Chronicled collaboration with software players such as In-House Applications empowers organizations to embrace disruptive technologies and accelerate their journey to the cloud, thus reshaping their business models.
| Reseller and SI | Vendor | Application | Category | Market |
|---|---|---|---|---|
| Chronicled | In-House Applications | Pharma Portal | Blockchain Platform | Blockchain |
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Product | Category | When | Insight |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cardinal Health | Healthcare | 53084 | $222.6B | United States | In-House Applications | Pharma Portal | Blockchain Platform | 2021 |
In 2021 Cardinal Health partnered with Chronicled to deploy a MediLedger blockchain-powered Pharma Portal as a Blockchain Platform to improve pharmaceutical chargeback accuracy and enhance connectivity between suppliers and customers in the United States. The engagement focused on embedding immutable transaction records and validation controls into Cardinal Health environments to support more reliable chargeback processing across commercial channels.
The Pharma Portal deployment implemented ledger-based transaction recording, reconciliation logic, and automated dispute flagging consistent with Blockchain Platform capabilities for provenance and validation. Configuration work included modeling chargeback event schemas, establishing identity and permission models for trading partners, and encoding business rules to trigger reconciliation workflows and notifications.
Integrations connected the Pharma Portal to Cardinal Health billing and chargeback systems and to internal portals and in-house applications to ingest supplier submissions and customer claims. Operational coverage emphasized United States supplier and customer connectivity, aligning supply chain and finance data flows to a shared transaction ledger for synchronized chargeback settlement.
Chronicled served as the implementation partner and supported onboarding and governance processes for trading partner identities and dispute escalation. Outcomes reported in the engagement centered on improved chargeback accuracy and reduced disputes through automated reconciliation and shared ledger visibility.
|
|
|
Novartis | Life Sciences | 75883 | $51.7B | Switzerland | In-House Applications | Pharma Portal | Blockchain Platform | 2019 |
In 2019, Novartis integrated MediLedger blockchain capabilities into its in-house Pharma Portal as part of participation in the MediLedger DSCSA pilot focused on interoperable track and trace and product verification across the pharmaceutical supply chain. The Pharma Portal implementation is described as a Blockchain Platform integration and was scoped to provide access to verification and chargeback related services within supply chain and regulatory compliance workflows.
Functional modules embedded in the Pharma Portal included serialization record access, interoperable product verification lookup services, and chargeback reconciliation endpoints, reflecting standard Blockchain Platform capabilities for immutable event recording and consensus based verification. Configuration work emphasized API exposure and user interface extensions in existing in-house applications so internal users could query MediLedger verification services and record serialized movement events.
Chronicled served as the system integrator for the MediLedger pilot integration into the Pharma Portal, enabling secure connectivity between Novartis internal systems and the consortium ledger. Operational coverage aligned with pharmaceutical supply chain functions and US prescription distribution channels under the DSCSA pilot, with the Pharma Portal acting as the internal access point to ledger based verification services.
Governance and rollout conformed to consortium and DSCSA compliance rules, driving process changes around standardized serialization data models, permissioned access controls, and event attestation workflows within the Pharma Portal. The implementation prioritized embedding Blockchain Platform verification capabilities into existing operational processes and in-house applications rather than replacing core enterprise systems.
|
|
|
Pfizer | Life Sciences | 81000 | $63.6B | United States | In-House Applications | Pharma Portal | Blockchain Platform | 2019 |
In 2019, Pfizer participated in the MediLedger DSCSA pilot to support pharmaceutical supply-chain traceability and product verification in the United States, using the MediLedger network for saleable returns and related verification workflows, in collaboration with Chronicled. The engagement tied Pfizer systems to a Blockchain Platform and focused on enabling interoperable verification flows required under the Drug Supply Chain Security Act.
Pfizer integrated MediLedger-based verification into its internal Pharma Portal and other in-house applications to consume serialization and verification services for DSCSA compliance. Implementations centered on serialization data ingestion, transaction-level verification calls, and saleable returns workflows, with the Pharma Portal acting as the application layer that initiates and displays verification responses from the Blockchain Platform.
Architecturally the integration relied on the MediLedger network as the decentralized verification layer and Pfizer in-house applications as the consumer layer, with API and adapter style interfaces inferred to mediate serialization lookups and cryptographic verification requests. Operational scope was explicitly the United States prescription supply chain, impacting supply-chain operations, returns management, and regulatory compliance teams that routed verification and disposition decisions through the Pharma Portal.
Governance and rollout were conducted within the MediLedger pilot framework, aligning standardized verification workflows and data exchange rules across participating manufacturers and trading partners, with Chronicled participating as the network implementation partner. The project was positioned to enable DSCSA-aligned serialization and product verification through Pfizers Pharma Portal integration with the Blockchain Platform, without asserting specific operational outcomes beyond the stated compliance objective.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Buyer Intent: Companies Evaluating Chronicled Services
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||